Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Aqueous micellar systems containing Triton X-114 and Pichia pastoris fermentation supernatant: A novel alternative for single chain-antibody fragment purification

Full text
Malpiedi, Luciana P. [1, 2] ; Nerli, Bibiana B. [2] ; Abdala, Dulcineia S. P. [3] ; Pessoa-Filho, Pedro de Alcantara [4] ; Pessoa, Jr., Adalberto [1]
Total Authors: 5
[1] Univ Sao Paulo, Biochem & Pharmaceut Technol Dept, FCF, BR-05508000 Sao Paulo - Brazil
[2] Univ Nacl Rosario, CONICET, Lab Fisicoquim Aplicada Bioseparac, Inst Proc Biotecnol & Quim IPROBYQ, RA-2000 Rosario, Santa Fe - Argentina
[3] Univ Sao Paulo, Clin & Toxicol Anal Dept, FCF, BR-05508000 Sao Paulo - Brazil
[4] Univ Sao Paulo, Dept Chem Engn, Sch Engn, BR-05508000 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Separation and Purification Technology; v. 132, p. 295-301, AUG 20 2014.
Web of Science Citations: 7

The main goal of this work was to evaluate the feasibility of using aqueous micellar two-phase systems (AMTPS) of Triton X-114 to purify a single-chain antibody fragment (scFv) directly from yeast fermentation supernatant. The coexistence curves of aqueous micellar two-phase systems, highly loaded (up to 90% wt/wt) with the biological feedstock, were determined. Besides, the effect of several additives such as inorganic salts and affinity ligands on the phase separation behavior was investigated. The obtained coexistence curves demonstrated that the assayed surfactant/yeast broth solutions were able to separate into two phases at temperatures lower than 24 degrees C. This information was then utilized to assay scFv partitioning and purification. In general, proteins present in the yeast broth, including the scFv, partitioned to the top, micelle-depleted phase due to its hydrophilic character. When affinity ligands were used, an opposite behavior was observed for scFv due to the uneven partitioning of ligands toward the micellar-rich phase. The best purification performances were attained for the system consisting of 4% wt/wt of Triton X-114, 60% wt/wt of yeast fermentation supernatant and the synthetic ligand Fabsorbent (TM) F1P HF, with a recovery percentage of 88% and a purification factor of 2. These results demonstrate the potential applicability of these systems for designing early steps for scFv purification directly from yeast broth. New perspectives are now open for the use of this methodology for recombinant antibody fragments purification. (C) 2014 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 11/20521-0 - Extraction of monoclonal antibody fragments type scFv by aqueous two-phase micellar systems
Grantee:Luciana Pellegrini Malpiedi
Support type: Scholarships in Brazil - Post-Doctorate